TALK vs. PGNY, GRAL, NHC, TDOC, VRDN, AHCO, CDNA, AGL, AVAH, and PNTG
Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Progyny (PGNY), GRAIL (GRAL), National HealthCare (NHC), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), Aveanna Healthcare (AVAH), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry.
Talkspace vs. Its Competitors
Progyny (NASDAQ:PGNY) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.
Progyny has a net margin of 4.33% compared to Talkspace's net margin of 1.51%. Progyny's return on equity of 10.90% beat Talkspace's return on equity.
Progyny has higher revenue and earnings than Talkspace. Progyny is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.
Progyny has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.
Progyny presently has a consensus target price of $24.09, suggesting a potential upside of 4.61%. Talkspace has a consensus target price of $4.50, suggesting a potential upside of 78.22%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than Progyny.
94.9% of Progyny shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 9.4% of Progyny shares are held by insiders. Comparatively, 23.5% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Progyny had 9 more articles in the media than Talkspace. MarketBeat recorded 13 mentions for Progyny and 4 mentions for Talkspace. Talkspace's average media sentiment score of 1.71 beat Progyny's score of 0.96 indicating that Talkspace is being referred to more favorably in the news media.
Summary
Progyny beats Talkspace on 10 of the 17 factors compared between the two stocks.
Get Talkspace News Delivered to You Automatically
Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Talkspace Competitors List
Related Companies and Tools
This page (NASDAQ:TALK) was last updated on 7/17/2025 by MarketBeat.com Staff